Napoleone Ferrara
Fondateur chez Theia Therapeutics, Inc.
Postes actifs de Napoleone Ferrara
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| University of California | Corporate Officer/Principal | - | - |
Catalio Capital Management LP
 Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Private Equity Investor | - | - |
| Theia Therapeutics, Inc. | Fondateur | - | - |
Gemini Pharmaceuticals, Inc.
 Gemini Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gemini Pharmaceuticals, Inc. manufactures pharmaceutical products. It offers dietary supplements, herbs and nutritional products. The firm's products include male and female libido enhancers, breast enhancers, smoking cessation supplements, weight loss supplements, multivitamins, digestive aids and painkillers towards pets. Gemini Pharmaceuticals was founded in 1982 and is headquartered in Commack, NY. | Consultant / Advisor | - | - |
Inflammasome Therapeutics, Inc.
 Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Napoleone Ferrara
Anciens postes connus de Napoleone Ferrara
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
| KINTARA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 22/06/2018 | - |
| Independent Dir/Board Member | 22/06/2018 | - |
Formation de Napoleone Ferrara
| University of Catania | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
| Italie | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KINTARA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
| Theia Therapeutics, Inc. | |
Gemini Pharmaceuticals, Inc.
Gemini Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gemini Pharmaceuticals, Inc. manufactures pharmaceutical products. It offers dietary supplements, herbs and nutritional products. The firm's products include male and female libido enhancers, breast enhancers, smoking cessation supplements, weight loss supplements, multivitamins, digestive aids and painkillers towards pets. Gemini Pharmaceuticals was founded in 1982 and is headquartered in Commack, NY. | Health Technology |
Inflammasome Therapeutics, Inc.
Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Health Technology |
- Bourse
- Insiders
- Napoleone Ferrara
- Expérience
